News Updates

Open Call to Contribute Clinical Strains of Mycobacterium tuberculosis to OAR

posted May 17, 2010, 12:49 AM by Domain Administrator   [ updated May 17, 2010, 2:58 AM ]

Open Source Drug Discudy overy (OSDD) programme of government of India is a CSIR led team India consortium with global partnerships. It is focussed on discovering drugs for Tuberculosis and making them available to patients at an affordable cost through collaborative research involving scientists, medical professionals, researchers, students and others who can meaningfully contribute to drug discovery.

To understand the biology of TB infection in the country, particularly in the context of drug resistance, it is necessary to study the diversity of Mycobacterium tuberculosis strains in the country. While some studies have already pointed to existence of such a diversity, in view the technological tools that are now available it is necessary to collect and analyse the variation across the country.

In addition, OSDD realises that access to research materials for researchers is essential for furthering drug discovery process. Ideally a researcher on TB anywhere in the country should be able to access strains, DNA, proteins and so on of Mtb for carrying out research. OSDD will provide such research materials free of cost to any researcher anywhere in the country, provided such researcher agrees to share the research results with the community.

All strains contributed will be tagged with the contributors name and it shall be a condition of access that due credits and acknowledgements should be provided in any publication that comes out of the study on the strains so accessed. The contributions will also be acknowledged on the OSDD website

It will be the first time that such an open access repository for clinical strains of Mtb will be created. Hope you will contribute to this national endeavour.

OSDD Announces creation of an Open Access Repository

posted May 16, 2010, 12:52 AM by Domain Administrator   [ updated May 17, 2010, 2:57 AM ]

Access to research material and resources is one of the major constrains that researchers face. Faster access to a standard set of resources not only would acceerate the pace of research in Tuberculosis, but also would enable the comparison and integration of research data. Identifying access limitations as a major roadblock for accelerated reseacrh into discovering novel therapeutics for Tuberculosis,  OSDD announces the creation of an Open Access Repository for research material. This includes repository of clinical isolates, small molecules and clones and proteins.
The resource would be populated both by contributions from researchers, clinicians and organisations including pharmaceutical Industries, and would be available to all free of cost through the OSDD portal on request. All data generated on the reosurce would be governed by the OSDD Licence.

1-2 of 2